Enterprise Products Partners Other Non-Current Liabilities increased by 4.5% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $915.00M to $1.03B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 7.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $729.50M | $771.20M | $760.00M | $801.00M | $898.00M | $938.00M | $941.00M | $965.00M | $915.00M | $1.01B | $984.00M | $912.00M | $992.00M | $1.06B | $950.00M | $915.00M | $934.00M | $903.00M | $984.00M | $1.03B |
| QoQ Change | — | +5.7% | -1.5% | +5.4% | +12.1% | +4.5% | +0.3% | +2.6% | -5.2% | +10.1% | -2.3% | -7.3% | +8.8% | +6.9% | -10.4% | -3.7% | +2.1% | -3.3% | +9.0% | +4.5% |
| YoY Change | — | — | — | — | +23.1% | +21.6% | +23.8% | +20.5% | +1.9% | +7.4% | +4.6% | -5.5% | +8.4% | +5.3% | -3.5% | +0.3% | -5.8% | -14.8% | +3.6% | +12.3% |